Doctors use scans to predict how lung cancer will respond to treatment
NCT ID NCT04151940
Summary
This study aims to learn how advanced lung cancer responds to a combination of chemotherapy, immunotherapy, and radiation by closely watching changes on PET/CT scans. It will enroll 80 patients with stage IV non-small cell lung cancer who are starting this standard treatment. The main goal is to see if early scan changes can help doctors better predict which patients might benefit most from the therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC LUNG NON-SMALL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fred Hutch/University of Washington Cancer Consortium
RECRUITINGSeattle, Washington, 98109, United States
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.